Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2021 Filed Aug 4, 2021 15:12 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 6.5665 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023026 · form4.xml · derivative · entry 6 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31.2516 Underlying: Common Stock · 6.5665 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 17, 2021 Filed Aug 4, 2021 15:17 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 15.6878 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023028 · form4.xml · derivative · entry 7 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149.5439 Underlying: Common Stock · 15.6878 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 17, 2021 Filed Aug 4, 2021 15:19 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 28.4559 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023029 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327.2852 Underlying: Common Stock · 28.4559 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 17, 2021 Filed Aug 5, 2021 13:03 UTC |
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
|
GrantRestricted Stock Units · Derivative | 116.4526 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023134 · form4.xml · derivative · entry 6 FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,212.9419 Underlying: Common Stock · 116.4526 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 17, 2021 Filed Aug 9, 2021 20:26 UTC |
Moeller Jon RVice Chairman and COO
|
GrantRestricted Stock Units · Derivative | 135.7247 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023350 · form4.xml · derivative · entry 5 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,792.2212 Underlying: Common Stock · 135.7247 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 17, 2021 Filed Aug 9, 2021 20:28 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 76.1531 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023353 · form4.xml · derivative · entry 3 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,871.6207 Underlying: Common Stock · 76.1531 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 17, 2021 Filed Aug 9, 2021 23:57 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 170.917 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023400 · form4.xml · derivative · entry 8 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,490.7317 Underlying: Common Stock · 170.917 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:21 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,952 | $0.00 Strike: $67.52 | $0.00 |
DisclosureSEC source: 0001127602-21-016568 · form4.xml · derivative · entry 5 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,952 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:21 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 22,952 | $136.46 | $3,132,029.92 |
DisclosureSEC source: 0001127602-21-016568 · form4.xml · nonDerivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,820.196 Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:21 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionCommon Stock | 22,952 | $67.52 | $1,549,719.04 |
DisclosureSEC source: 0001127602-21-016568 · form4.xml · nonDerivative · entry 2 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,772.196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:21 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 1,458 | $136.12 | $198,464.71 |
DisclosureSEC source: 0001127602-21-016568 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,820.196 F1 · price: Weighted average price of the shares sold. The price range was $136.10 to $136.13. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:17 UTC |
Bishop Steven DCEO - Health Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $78.66 | $0.00 |
DisclosureSEC source: 0001127602-21-016562 · form4.xml · derivative · entry 5 Bishop Steven D · CIK 0001669212 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,797 Underlying: Common Stock · 60,000 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:17 UTC |
Bishop Steven DCEO - Health Care
|
SaleCommon Stock | 60,000 | $138.50 | $8,310,000.00 |
DisclosureSEC source: 0001127602-21-016562 · form4.xml · nonDerivative · entry 2 Bishop Steven D · CIK 0001669212 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,677.8862 Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:17 UTC |
Bishop Steven DCEO - Health Care
|
Exercise / conversionCommon Stock | 60,000 | $78.66 | $4,719,600.00 |
DisclosureSEC source: 0001127602-21-016562 · form4.xml · nonDerivative · entry 1 Bishop Steven D · CIK 0001669212 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,677.8862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:19 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
SaleCommon Stock | 3,513 | $137.27 | $482,242.86 |
DisclosureSEC source: 0001127602-21-016564 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,935.7086 Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:23 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-21-016570 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,202 Underlying: Common Stock · 55,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:23 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 55,000 | $138.25 | $7,603,475.00 |
DisclosureSEC source: 0001127602-21-016570 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,287.8142 F1 · price: Weighted average price of the shares sold. The price range was $138.32 to $138.20. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:23 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 55,000 | $85.13 | $4,682,150.00 |
DisclosureSEC source: 0001127602-21-016570 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,287.8142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 11, 2021 17:26 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 4,500 | $137.91 | $620,608.95 |
DisclosureSEC source: 0001127602-21-016179 · form4.xml · nonDerivative · entry 2 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,511 F1 · price: Weighted average price of the shares sold. The price range was $137.90 to $137.93. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| May 07, 2021 Filed May 10, 2021 20:19 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 68,275 | $0.00 Strike: $69.45 | $0.00 |
DisclosureSEC source: 0001127602-21-016048 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,275 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 10, 2021 20:19 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 68,275 | $135.47 | $9,249,262.04 |
DisclosureSEC source: 0001127602-21-016048 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,287.8142 F1 · price: Weighted average price of the shares sold. The price range was $135.23 to $135.74. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| May 07, 2021 Filed May 10, 2021 20:19 UTC |
Taylor David SDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 68,275 | $69.45 | $4,741,698.75 |
DisclosureSEC source: 0001127602-21-016048 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,562.8142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2021 Filed May 7, 2021 01:54 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
OtherCommon Stock | 329,929 | $135.14 | $44,586,605.06 |
DisclosureSEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 6 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 5,786,361 F9 · kind: Represents a distribution of shares to the limited partner in the parent entity of a Trian Entity in connection with the winding down of such Trian Entity. F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| May 06, 2021 Filed May 7, 2021 01:54 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 6,000 | $135.01 | $810,072.00 |
DisclosureSEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 5 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 6,116,290 F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer. F8 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $134.995 to $135.015. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| May 06, 2021 Filed May 7, 2021 01:54 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 990,387 | $134.63 | $133,338,277.78 |
DisclosureSEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 4 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 6,122,290 F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer. F7 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $134.00 to $134.99. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| May 06, 2021 Filed May 10, 2021 13:13 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
SaleCommon Stock | 3,000 | $135.00 | $405,000.00 |
DisclosureSEC source: 0001127602-21-015960 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,085.48 Read SEC document |
| May 05, 2021 Filed May 7, 2021 01:54 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 766,810 | $134.30 | $102,983,273.13 |
DisclosureSEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 3 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 7,112,677 F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer. F6 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $134.00 to $134.91. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| May 04, 2021 Filed May 7, 2021 01:54 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 62,770 | $135.29 | $8,492,228.62 |
DisclosureSEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 2 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 7,879,487 F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer. F5 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $135.2450 to $135.42. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| May 04, 2021 Filed May 7, 2021 01:54 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 937,230 | $134.61 | $126,161,654.98 |
DisclosureSEC source: 0001209191-21-030779 · doc4.xml · nonDerivative · entry 1 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 7,942,257 F1 · kind: Represents the sales of shares in connection with the expiration of the applicable lock-up periods of two Trian Entities (as defined below) holding shares of the Issuer. F2 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $134.25 to $135.24. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:22 UTC |
Moeller Jon RVice Chairman and COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,975 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-21-015528 · form4.xml · derivative · entry 8 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 22,975 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:22 UTC |
Moeller Jon RVice Chairman and COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 132,151 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-21-015528 · form4.xml · derivative · entry 7 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 132,151 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:22 UTC |
Moeller Jon RVice Chairman and COO
|
SaleCommon Stock | 22,975 | $134.64 | $3,093,264.40 |
DisclosureSEC source: 0001127602-21-015528 · form4.xml · nonDerivative · entry 4 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 5,586.9821 F2 · price: Weighted average price of the shares sold. The price range was $134.62 to $134.70. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:22 UTC |
Moeller Jon RVice Chairman and COO
|
Exercise / conversionCommon Stock | 22,975 | $85.13 | $1,955,861.75 |
DisclosureSEC source: 0001127602-21-015528 · form4.xml · nonDerivative · entry 3 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 28,561.9821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:22 UTC |
Moeller Jon RVice Chairman and COO
|
SaleCommon Stock | 132,151 | $134.61 | $17,788,859.33 |
DisclosureSEC source: 0001127602-21-015528 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,671.9888 F1 · price: Weighted average price of the shares sold. The price range was $134.25 to $135.03. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:22 UTC |
Moeller Jon RVice Chairman and COO
|
Exercise / conversionCommon Stock | 132,151 | $85.13 | $11,250,014.63 |
DisclosureSEC source: 0001127602-21-015528 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,822.9888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2021 Filed Apr 23, 2021 15:34 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
SaleCommon Stock | 12,872 | $135.47 | $1,743,769.84 |
DisclosureSEC source: 0001127602-21-014321 · form4.xml · nonDerivative · entry 1 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,428.5832 Read SEC document |
| April 21, 2021 Filed Apr 22, 2021 18:44 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 2,285 | $137.99 | $315,307.15 |
DisclosureSEC source: 0001127602-21-014255 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 5,733.2883 Read SEC document |
| April 21, 2021 Filed Apr 22, 2021 18:44 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 10,383 | $137.99 | $1,432,750.17 |
DisclosureSEC source: 0001127602-21-014255 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,016.6703 Read SEC document |
| April 21, 2021 Filed Apr 22, 2021 19:23 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
SaleCommon Stock | 3,750 | $137.14 | $514,257.38 |
DisclosureSEC source: 0001127602-21-014268 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,085.48 F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| April 01, 2021 Filed Apr 1, 2021 19:28 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 571 | $133.53 | $76,243.29 |
DisclosureSEC source: 0001127602-21-012565 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,278.196 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 18:53 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010019 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 18:55 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010020 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,361.7748 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 18:57 UTC |
BLAKE FRANCIS SDirector
|
GrantCommon Stock | 199 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010021 · form4.xml · nonDerivative · entry 1 BLAKE FRANCIS S · CIK 0001194702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,549.041 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 18:58 UTC |
Chang AmyDirector
|
GrantCommon Stock | 199 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010022 · form4.xml · nonDerivative · entry 1 Chang Amy · CIK 0001551504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,677.508 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:00 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010023 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,524.194 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:01 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 248 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010024 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,289.839 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:02 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010025 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,313.525 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:03 UTC |
MCNERNEY W JAMES JRDirector
|
GrantCommon Stock | 278 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010026 · form4.xml · nonDerivative · entry 1 MCNERNEY W JAMES JR · CIK 0001182055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,785.565 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 19:04 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010027 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,913.15 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 19:59 UTC |
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
|
SaleCommon Stock | 1,219 | $125.77 | $153,315.34 |
DisclosureSEC source: 0001127602-21-008051 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,448.7086 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $124.58 to $126.54. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.